Biotech, Banking Expert to Address Entrepreneurs and Investment Community at BIO MidAmerica VentureForum

  • Contact: Kimberly Allen, BIO (202) 962-9200
    Joe Poulos, Ashton Partners (312) 553-6702
  • Recommend
  • Tweet
  • Print
  • Email

WASHINGTON, D.C. (March 20, 2003)— The Biotechnology Industry Organization (BIO) today announced that Stelios Papadopoulos, a leading expert in biotechnology and banking, will be a featured keynote speaker at the upcoming BIO Mid-America VentureForum at the Hotel Inter-Continental in Chicago, April 3-4.

Papadopoulos, vice chairman of SG Cowen, will address future trends in the biotechnology and pharmaceutical industries with regard to opportunities in venture capital at a luncheon on April 3 at noon. SG Cowen provides securities and investment banking services to corporate clients and institutional investors worldwide.

“Stelios has remarkable insight into both the scientific and business development trends in our industry,” said Carl B. Feldbaum, president of BIO. “He is a compelling speaker who calls circumstances exactly as he sees them.”

The BIO conference will give seed, early and late-stage private companies searching for private equity funding the opportunity to meet and network with venture capitalists and investors. Approximately 70 Midwest biotechnology firms will present their business plans at the two-day conference.

Prior to joining SG Cowen in 2000, Papadopoulos spent 13 years as an investment banker at Paine Webber, focusing on the biotech and pharmaceutical sectors. He previously worked for both Drexel Burnham Lambert and Donaldson, Lufkin & Jenrette.

Before embarking on a career on Wall Street, Papadopoulos served on the faculty of the Department of Cell Biology at New York University Medical Center, where he continues his affiliation today as an adjunct associate professor. Papadopoulos has a Ph.D. in biophysics and an MBA in finance, both from NYU.

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and in 33 other countries. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products. For more information, please visit www.bio.org.


###

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.